Syngenis One, the engine behind an integrated life sciences company.
One platform, one set of Australian laboratories, and six connected pillars that share the same engine, so the value of every discovery extends across the whole business.
What Syngenis One is.
Syngenis One is the digital and scientific backbone of the company. It brings AI led discovery, thermodynamic and off target analysis, synthesis ordering, manufacturing workflow and program management into one connected system. Researchers design candidates in the AI Discovery module, then order the material through the same system, with full traceability from a gene of interest to trial ready product. Nothing is rebuilt or revalidated as work moves from one stage to the next, because it never leaves the platform.
Why an integrated platform beats a chain of suppliers.
Traditionally, a nucleic acid program is assembled from a chain of separate providers: one for target databases, another for design tools, another for synthesis, another for characterisation, another for clinical work. Every hand off adds time, cost, revalidation and intellectual property exposure. Syngenis One removes the hand offs. Discovery, manufacture and clinical delivery share one chain of custody, one quality framework and one accountable partner.
How a discovery moves through Syngenis.
Discover
Syngenis One (AI Discovery) identifies and ranks targets from the biology.
Design
It designs RNA and DNA candidates and calculates their biophysical properties.
Validate
Off target screening and in silico trial modelling reduce risk before the bench.
Order and make
Confirmed candidates are ordered through the Syngenis One system and synthesised in our own laboratories.
Advance
Our specialist CRO carries programs into regulated clinical work.
Scale
Research grade to GMP grade manufacturing supports growth, all on home soil.
Why integration matters.
- Speed. What took months of manual work across disconnected tools now happens in one guided workflow.
- Protection. Keeping discovery and manufacture together keeps intellectual property in one place, in Australia.
- Compliance. No repeated validation or regulatory rebuild every time work changes hands.
- Compounding value. Every program that runs through Syngenis One strengthens every other part of the platform.
Ready to work with an integrated life sciences company?
Talk to our team about your program, from candidate design to trial ready material.
One engine, working across the whole business.
Syngenis One (AI Discovery)
Design RNA and DNA candidates from target to synthesis ready oligo in one workflow.
Manufacturing
Australia's only commercial RNA facility. Custom oligonucleotides, ordered through Syngenis One.
Research and Diagnostics
AI led therapeutic programs and an aptamer based diagnostics pipeline.
Clinical
A specialist nucleic acid CRO with in silico trial modelling.
Life Care
Consumer genomics at a mass market price.
Fund
Infrastructure that channels research investment into the pipeline.